Assignee
GEISTLICH PHARMA AG
CH·27 granted patents·7 pending applications·58 citations·filing 2008–2024
Top patents by PatentIndex Score
34 records- 0195US9844555B2Oxathiazine derivatives as antibacterial and anticancer agentsGEISTLICH PHARMA AG·Filed 2017·Granted Dec 19, 2017·9 cites·16 claims
- 0294US9624187B2Oxathiazine derivatives as antibacterial and anticancer agentsGEISTLICH PHARMA AG·Filed 2015·Granted Apr 18, 2017·6 cites·27 claims
- 0394US9241943B2Oxathiazine derivatives as antibacterial and anticancer agentsGEISTLICH PHARMA AG·Filed 2013·Granted Jan 26, 2016·9 cites·15 claims
- 0493US11999709B2Processes for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2023·Granted Jun 4, 2024·2 cites·20 claims
- 0592US11591302B2Processes for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2021·Granted Feb 28, 2023·3 cites·20 claims
- 0692US10968190B2Processes for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2019·Granted Apr 6, 2021·4 cites·20 claims
- 0789US10392355B2Processes for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2015·Granted Aug 27, 2019·4 cites·21 claims
- 0888US10736902B2Method of treating triple negative breast cancerGEISTLICH PHARMA AG·Filed 2017·Granted Aug 11, 2020·3 cites·21 claims
- 0984US12534443B2Processes for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2024·Granted Jan 27, 2026·0 cites·19 claims
- 1079US10835640B2Resorbable crosslinked form stable membrane for use outside the oral cavityGEISTLICH PHARMA AG·Filed 2018·Granted Nov 17, 2020·4 cites·16 claims
- 1177US10695461B2Dried implant composition and injectable aqueous implant formulationGEISTLICH PHARMA AG·Filed 2018·Granted Jun 30, 2020·2 cites·20 claims
- 1274US10869949B2Method for treating subjects suffering from chronic ulcersGEISTLICH PHARMA AG·Filed 2020·Granted Dec 22, 2020·1 cites·30 claims
- 1374US10646615B2Bone substitute materialGEISTLICH PHARMA AG·Filed 2019·Granted May 12, 2020·1 cites·19 claims
- 1469US9655997B2Collagen spongeGEISTLICH PHARMA AG·Filed 2015·Granted May 23, 2017·1 cites·15 claims
- 1568US10300171B2Resorbable crosslinked form stable membraneGEISTLICH PHARMA AG·Filed 2018·Granted May 28, 2019·1 cites·19 claims
- 1662US11633519B2Dried implant composition and injectable aqueous implant formulationGEISTLICH PHARMA AG·Filed 2020·Granted Apr 25, 2023·0 cites·18 claims
- 1762USRE48536ECollagen spongeGEISTLICH PHARMA AG·Filed 2019·Granted Apr 27, 2021·0 cites·27 claims
- 1861US10544114B2Process for preparing oxathiazin-like compoundsGEISTLICH PHARMA AG·Filed 2017·Granted Jan 28, 2020·0 cites·9 claims
- 1959US2026021106A1Combination therapy for treating cancersGEISTLICH PHARMA AG·Filed 2023·Application pending·0 cites
- 2058US11571494B2Method for treating subjects suffering from chronic ulcersGEISTLICH PHARMA AG·Filed 2020·Granted Feb 7, 2023·0 cites·30 claims
- 2158US2009163479A1Use of taurolidine to treat tumorsGEISTLICH PHARMA AG·Filed 2008·Application pending·0 cites
- 2256US2024199563A1Antimicrobial and anticancer agentsGEISTLICH PHARMA AG·Filed 2022·Application pending·0 cites
- 2356US2026027126A1Combination therapy for treating cancersGEISTLICH PHARMA AG·Filed 2023·Application pending·0 cites
- 2452US11351287B2Bone substitute materialGEISTLICH PHARMA AG·Filed 2018·Granted Jun 7, 2022·0 cites·20 claims
- 2552US10960107B2Collagen matrix or granulate blend of bone substitute materialGEISTLICH PHARMA AG·Filed 2020·Granted Mar 30, 2021·0 cites·20 claims
- 2652US10918592B2Injectable aqueous implant formulation containing ascorbic acidGEISTLICH PHARMA AG·Filed 2020·Granted Feb 16, 2021·0 cites·19 claims
- 2751US11357891B2Collagen matrix or granulate blend of bone substitute materialGEISTLICH PHARMA AG·Filed 2020·Granted Jun 14, 2022·0 cites·19 claims
- 2850US10029028B2Biomimetic collagen-hydroxyapatite composite materialGEISTLICH PHARMA AG·Filed 2014·Granted Jul 24, 2018·0 cites·17 claims
- 2949US12514847B2Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine releaseGEISTLICH PHARMA AG·Filed 2020·Granted Jan 6, 2026·0 cites·16 claims
- 3048US10646619B2Bone substitute materialGEISTLICH PHARMA AG·Filed 2018·Granted May 12, 2020·0 cites·18 claims
- 3147US2022323452A1Methods and compositions for inhibiting gapdhGEISTLICH PHARMA AG·Filed 2020·Application pending·0 cites
- 3247US2023389911A1Applicator of a spongeous collagen membrane and kit comprising such applicator and membraneGEISTLICH PHARMA AG·Filed 2021·Application pending·0 cites
- 3345USD812762SCollagen membraneGEISTLICH PHARMA AG·Filed 2015·Granted Mar 13, 2018·8 cites·1 claims
- 3445US2022313702A1Oxathiazin compounds for inhibiting gapdhGEISTLICH PHARMA AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GEISTLICH PHARMA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →